KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Procter & Gamble (PG) Cash & Equivalents (2016 - 2025)

Procter & Gamble (PG) has disclosed Cash & Equivalents for 17 consecutive years, with $10.8 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 5.82% to $10.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.8 billion through Dec 2025, up 5.82% year-over-year, with the annual reading at $9.6 billion for FY2025, 0.78% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $10.8 billion at Procter & Gamble, down from $11.2 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $12.2 billion in Q3 2024, with the low at $6.7 billion in Q3 2022.
  • Average Cash & Equivalents over 5 years is $9.2 billion, with a median of $9.5 billion recorded in 2024.
  • The sharpest move saw Cash & Equivalents crashed 40.63% in 2022, then surged 45.05% in 2023.
  • Over 5 years, Cash & Equivalents stood at $11.5 billion in 2021, then plummeted by 40.63% to $6.9 billion in 2022, then grew by 15.12% to $7.9 billion in 2023, then grew by 29.66% to $10.2 billion in 2024, then increased by 5.82% to $10.8 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $10.8 billion, $11.2 billion, and $9.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.